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In this work were investigated the relationship between Hookworm/Schistosoma mansoni infections and
allergy related risk factors in two endemic areas with distinct prevalence of infections and co-infection.
The intensity of infections, eosinophilia, allergy risk factors, infections status and anti-Der p1 IgE levels
before and 2 years (population 1) and 3 years (population 2) after anthelmintic treatment, were eval-
uated. It was observed that the population with lower prevalence and intensity of infection (population
2) had lower eosinophils counts (4600/mm3) and higher animal contact than the population with
higher parasites intensity (population 1). After anthelmintic treatment the intensity of S. mansoni single
infection decreased, but no changes were observed in Hookworm and co-infected individuals. The
anthelmintic treatment also enhanced anti-Der p1 IgE optical density in ELISA on the subgroups that
became negative for helminth infection regardless of their previous infection condition in population 1.
Facing that, we evaluated the anti-Der p1 IgE reactivity index, and the ratio (after/before treatment) was
signiﬁcantly higher in patients co-infected before treatment. On the other hand, no association between
anti-Der p1 IgE reactivity index and the intensity of infections were observed. In conclusion, effective
anthelmintic therapy of subjects from endemic areas with high prevalence of Hookworm and S. mansoni
infections enhances anti-Der p1 IgE levels.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The relationship between environmental factors and allergic
disorders was ﬁrst published by Strachan [1]. The author proposed
the Hygiene Hypothesis, attributing the progressive growth of
numbers of allergic individuals in the last decades to the reduction
of infectious agents exposure during childhood. Immunologically,
infections can modify the immune responses and consequently
inhibit an exacerbated inﬂammatory condition. This phenomenon
can be explained by a perturbation of the immune responses
caused mostly by pathogens in which helminths play an important
role [2,3]. The effects of helminth infections upon the immune
responses to other health conditions are an area of great interest,
mainly because helminth infections are able induce immuneB.V. This is an open access article uregulation through stimulation of regulatory T cells and IL-10
production [4,5]. Previous studies [6,7] have shown that Schisto-
soma mansoni infection induces IL-10 production which leads to a
decrease in allergic symptoms.
In this context, additional studies of the effect of helminth
infections on allergic disorders are needed to better determine
whether these infections reduce allergic symptoms and if this is
dependant on the exposure conditions and sensitization. More-
over, it is important to determine whether treatment of indivi-
duals from endemic areas with anthelmintic drugs increase aller-
gic occurrence. Under this scope, our study aimed to investigate
the relationship between prevalence and intensity of S. mansoni
(SCH) and hookworm (HW) infection and IgE responses to Der-
matophagoides pteronyssinus antigen (Der p1) before and after
treatment as well as risk factors to allergy such as eosinophilnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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populations of medium and high S. mansoni transmission.2. Population, material and methods
2.1. Study area and population
The study was carried out in Caju (population-1) with 413
individuals and São Pedro do Jequitinhonha (population-2) with
314 individuals, 20 km distant from each other and both in the
Municipality of Jequitinhonha. These are poor rural endemic areas
for S. mansoni and hookworm infections. The population in Caju is
of 632 inhabitants that live by subsistence agriculture. São Pedro
do Jequitinhonha, which population is 2265 inhabitants, has
similar economic condition but is closer to a larger non-rural
community and is bordered by Jequitinhonha river. This region is
characterized by poor sanitation and social economic conditions
and the residents are constantly exposed to the risk of helminth
infections [8]. The entire population was screened for infection
and due to the fact that prevalence of infection was above 50%, all
inhabitants were treated. Follow up treatment was performed at
1 month post-therapy and yearly for the period of 5 years.
Informed consent was obtained for all volunteers, including chil-
dren. For adolescents, consent was obtained from the volunteer
and from its parents. The samples used were from two distinct
collection times in each locality: before treatment (2004/Caju and
2007/São Pedro do Jequitinhonha) and after treatment (2006/Caju
and 2010/São Pedro do Jequitinhonha). All participants were
registered and assigned unique household identiﬁcation (HHID)
and personal identiﬁcation numbers (PID). This study was
approved by the National Committee of Ethics in Research of Brazil
(CONEP/ 268/08).
2.2. Parasitological survey and eosinophils count
Parasitological survey was conducted using the Kato-Katz test.
All individuals living in the studied villages received three con-
tainers with identiﬁcation numbers for stool sample collection.
The recipients were collected on three consecutive days. On the
day of sample collection, all volunteers were submitted to a
questionnaire to collect additional information on socio-economic
status and activities as previously described by our group [8]. For
parasite egg detection and quantiﬁcation, two slides were pre-
pared for each sample, totalling six slides per participant.
Parasite burdens, as determined by eggs per gram of faeces
(epg), were calculated from the media of absolute egg number
multiplied by 24 and divided by the number of slides (6). The S.
mansoni infected adults were treated by single dose of Prazi-
quantel (50–60 mg/kg) while children were treated single dose of
Oxamniquine (20 mg/kg). Hookworm infected individuals were
treated by single dose of Albendazole (400 mg). All treatments
were given under medical supervision and according to Brazilian
Ministry of Health regulations.
The CBC (complete blood count) was performed using the
automated haematology system Advia 60 (Bayer Health Care,
USA). Eosinophilia was deﬁned as eosinophils count over
600/mm3.
2.3. Serum samples and ELISA
Serum was obtained by collection of blood in vacutainer tubes
and one additional tube containing EDTA was collected for hae-
matological analysis (Vacutainer, BD, EUA). Tubes were refri-
gerated and sent to the Laboratório de Imunologia Celular e
Molecular from Centro de Pesquisas René Rachou, where sampleswere aliquoted in microtubes and stored at 70 °C until use.
Serum IgE reactivity against D. pteronyssinus crude extract (Derp1,
LG 5449, Cosmo Bio Co. Ltd., Japan) antigen was tested using an
Enzyme Lynked Immunosorbent Assay (ELISA). Brieﬂy, each well
was coated with 100 mL of mite Der p1 antigen at the ﬁnal con-
centration of 1 mg/mL in phosphate buffer saline pH 7.2 (PBS 1 ).
The ELISA plates were incubated for 16 h at 4 °C, washed twice
with PBS Tween 20 (Biorad, USA) 0.05% and blocked with 200 mL of
PBS with 3% bovine serum albumin (BSA) for 1 h at 37 °C. The
serum samples were diluted 1:50 in PBS 1 with BSA at 3% and
were added to the wells and incubated for 2 h at 37 °C. The plates
were washed ﬁve times and incubated for 1 h at 37 °C, washed ﬁve
times again and incubated with 100 mL of peroxidase labelled
monoclonal antibody anti-human IgE (KPL, USA) for 1 h at 37 °C.
The assays were developed by addition of the substrate (H2O2,
Sigma-Aldrich Co., USA) and the chromogen (O-phenylenedia-
mine, Sigma-Aldrich Co., USA). The optical density was determined
using an automatic ELISA microplate reader at 492 nm (SpectrMax
340 PC reader, Molecular Devices, Sunnyvale, CA, USA) running
Softmax Pro software (Molecular Devices). A serum pool obtained
from urban area subjects and free of parasitic infection was used as
control sample.
2.4. Questionnaire used to obtain information about respiratory
disease
The interviews were held at the subject’s homes in 2011 (Caju)
and 2008 (São Pedro de Jequitinhonha). Children under 13 years
old had the questionnaire answered by their tutors. Data were
collected by a portable computer PDA-Personal Digital Assistant-
Dell-Axim X 50 (Dell Inc., Texas, EUA). The frequency of allergic
disorders was estimated by the International Study of Asthma and
Allergies in Childhood questionnaire. This questionnaire was cre-
ated to develop an epidemiological study of asthma and allergy
distributions worldwide and is divided in three phases with
questions of behavioural and environmental aspects. Questions of
the ﬁrst phase, related to previous symptoms and conﬁrmed
diagnosis of allergic disease, were used to estimate allergic dis-
orders distribution on these two localities. Furthermore, secondary
questions were asked to characterize the occurrence of risk factors
as contact with animals and smoking habit.
2.5. Statistical analysis
For statistical analysis were used Microsoft Excel 2010 SP1
(Microsoft Corporation, Washington, EUA) and Graph Pad Prism
5.0.3 (San Diego, CA, EUA). Chi-square, Mann–Whitney and
Tukey’s post-tests were used for multiple comparisons tests to
investigate differences between frequencies. In all cases, differ-
ences were considered signiﬁcant when po0.05.3. Theory
Long-term anthelminthic treatment can modify the allergen
speciﬁc immune response in S. mansoni and hookworm infected
individuals.4. Results
4.1. Prevalence of Hookworm and S. mansoni infections pre and
post-treatment
Our data demonstrated that the prevalence of HW infection as
well as HWþSCH co-infection were higher in population 1 when
S.S. Campolina et al. / Results in Immunology 5 (2015) 6–128compared to population 2 (Fig. 1A). No signiﬁcant differences were
observed on the age ranges as well as gender distribution between
the two localities (Fig. 1B). Population 1 also had higher intensity
of infection (Fig. 1C) in all age ranges as compared to population 2
(Fig. 1D). Moreover, population 1 also presented greater frequency
of individuals displaying high intensity S. mansoni infection
(Sm4100 epg) (Fig. 1E).
4.2. Analysis of anti-Der p1 antibody responses of individuals living
in endemic areas with distinct prevalences for Hookworm and S.
mansoni infections
To determine the effectiveness of the ELISA technique to
measure the serum levels of Anti-Der p1 IgE, we ﬁrst established
the optical density cut-off point of the assay. To determine this
point, the median of anti-Der p1 IgE optical density values from
both populations together before treatment was evaluated in
order to separate the individuals into “Low and High anti-Der p1
IgE producers” (Fig. 2A). The cut-off used to evaluate the data were
of reading on O.D. of 0.420.
Although population 2 showed a lower frequency of individuals
with eosinophilia (EOS4600/mm3), it had increased frequency of
individuals reporting animal contact, and 450% of “High anti-Der
p1 IgE producers”(Fig. 2B).
4.3. Effect of treatment on the frequency on high anti-Der p1 IgE
responder
Although the albendazole/praziquantel combined treatment
was unable to completely eradicate the helminthic infections inFig. 1. Prevalence of helminthic infections, demographical parameters and intensity of
state Brazil. The infected individuals were identiﬁed by Kato Katz examinations against
2 following the examinations results: negative in kato-Katz test (NEG/ white bar), positiv
dark grey bar) in Kato-Katz test and positive for co-infection with hookworm and S.
evaluated. (B) The intensity of infection was expressed as egg per grams in hookworm (An
(D) and the frequency of highly infected individuals was determined by Z 2000 epg
population 1 group was compared with their respective on the population 2. The error b
exact and by Mann–Whitney tests. In both cases signiﬁcance were considered at p o 0both studied populations, the frequency of negative (NEG) indi-
viduals in these localities increased (Fig. 3A). It is interesting to
note that combined anthelmintic therapy reduced the intensity of
S. mansoni (SCH) infection in single infected patients in the
population 1. However, it did not reduce the intensity of infection
in those individuals that remained HW infected or HWþSCH co-
infected after treatment (Fig. 3B). No signiﬁcant differences in the
intensity of infection were observed in the population 2 (Fig. 3B).
With the objective of identifying the effect of albendazole/
praziquantel anthelmintic therapy on the levels of anti-Der p1 IgE
antibody response, we categorized the studied populations into
two subgroups, referred as “TREATED-NEG” and “TREATED-POS”
since these individuals cleared the infection or remained infected
(or re-infected) 2 years after treatment. The re-infected and
infected participants were treated over again until the infection
clearance. The posterior data about repeatedly treatments were
not use on this study.
Our data demonstrated that the frequency of “High anti-Der p1
IgE producers” increased selectively in the TREATED-NEG sub-
group of population 1, with no signiﬁcant changes in the TREA-
TED-POS subgroup of population 1 neither in both subgroups of
population 2 (Fig. 4A).
Detailed analysis of TREATED-NEG and TREATED-POS sub-
groups based on their pre-treatment (Before-NEG, Before-HW,
Before-SCH and Before-HWþSCH) and post-treatment status
(After-NEG, After-HW, After-SCH and After-HWþSCH), further
demonstrated that, regardless of their pre-treatment condition,
the increased frequency of “High anti-Der p1 IgE producers” were
evenly distributed amongst the TREATED-NEG patients of popu-
lation 1 (Fig. 4B).infection related to age and parasite burden in two municipalities of Minas Gerais
hookworm and S. mansoni and the prevalence was estimated in populations 1 and
e for hookworm in kato-Katz test (HW/ light grey bar), positive for S. mansoni (SCH/
mansoni (HW þ SCH/ black bar). (A) The frequency of gender and age were also
c) and S. mansoni (Sm) infections. (C) Its distributions amongst different age ranges.
for hookworm (Anc) and Z 400 epg for S. mansoni (Sm). (E) The median of each
ars represent the interquartile range statistical analyses were performed by Fisher’s
.05 and highlighted by *.
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Fig. 2. Analyses of allergy related biomarkers and risk factors in two endemic areas for helminthic infection in Minas Gerais, Brazil. The global median value of to anti-Der p1
IgE reactivity was used as the cut-off to segregate “low” and “High producers”. The anti-Derp 1 values correspond to the absorbance before treatment (A). Five allergy related
biomarkers and risk factors, including anti-Der p1, peripheral blood eosinophil count (EOS4600/mm3), asthma, rhinitis and eczema previous episodes (As/Rh/Ec), animals
contact and smoking addiction were used to assess the likelihood of allergic disease, according to Isaac questionnaire. Individuals presenting more than one allergy risk
factor were also related (associationZ2). Each parameter of the population 1 was compared with the equivalent in population 2(B). Statistical analyses were performed by
Fisher’s exact and by Mann–Whitney tests. In both cases signiﬁcance were considered at po0.05 and highlighted by *. Although there was not a statistical signiﬁcance on the
frequency of higher anti-Der p1 producers, it was slightly higher on population 2 (#).
S.S. Campolina et al. / Results in Immunology 5 (2015) 6–12 94.4. Analysis of post-treatment anti-Der p1 Ige Index and its rela-
tionship with helminthic infection/co-infection status and infection
intensity
In order to further investigate whether the changes in the anti-
Der p1 IgE observed in the TREATED-NEG subgroup of population
1 could be related to the patient pre-treatment condition, we
calculated for each patient the anti-Der p1 Ige Index as the ratio
between the optical densities observed after/before treatment.
Interestingly, our data demonstrated that the anti-Der p1 Ige Index
was signiﬁcantly higher in the subgroup of patients with co-
infection status before treatment (Before-HWþSCH) (Fig. 5A).
Additional analysis demonstrated that the increase on the anti-Der
p1 Ige Index was not associated with either the intensity of
Hookworm or the S. mansoni egg counts (Fig. 5B).5. Discussion
Although several authors have evaluated changes in anti-Der
p1 responses following anthelmintic treatment [9,10], in this study
we performed comparisons of anti-Der p1 IgE response before and
after treatment in all age range and in both genders. The popula-
tions evaluated had similar age and gender parameters and also
allergy risk factors were equally distributed. Treatment against S.
mansoni and hookworm was effective in both localities as indi-
cated by negative individuals’ stool egg counts. We also observed
that re-infection frequently occurs.
Furthermore, we demonstrated that anti-Der p1 IgE levels
increased after treatment on population with higher intensity of
infection. Worms are known as master pieces on immune reg-
ulation and are commonly associated with allergy downregulation.
Fig. 3. Impact of treatment on prevalence and intensity of infection in two endemic areas for helminthic infection in Minas Gerais, Brazil. The prevalence of infection before
and after treatment was determinate for each one of these conditions: individuals with negative kato-Katz test (NEG) were represented by white bar; hookworm positive
individuals on kato-Katz test (HW) were represented by light grey bar; positive individuals for S. mansoni on Kato-Katz test (SCH) were represented by dark grey bar and co-
infected individuals determinated by Kato-Katz test (HW þ SCH) were represented by black bar (A). The intensity of hookworm (Anc) and S. mansoni (Sm) infections was
also evaluated before and 2 years after treatment and the absolute number obtained on Kato-Katz test was also used. The medians of each group of the populations were
compared before and after treatment with their respective groups. The error bars represent the interquartile range. Statistical analyses were performed by Fisher’s exact and
by Mann–Whitney tests. In both cases signiﬁcance were considered at po0.05 and highlighted by *.
S.S. Campolina et al. / Results in Immunology 5 (2015) 6–1210Van den Biggelaar and colleagues [10], showed an association
between S. mansoni infection and IL-10 production on patients
serum. IL-10, combined or not with TGF-β, secreted by antigen
presenting cells and regulatory T cells may directly interfere with
allergic effectors mechanisms by inhibiting mast cell degranula-
tion or Th2 immune response [11,12]. This mechanism was cor-
roborated in animal models demonstrating that allergic immune
response was suppressed by helminthes and this event was
related to IL-10 increase production and regulatory
CD4þFoxp3þCD45þ T cells [13].
Moreover, it has also been previously shown that PBMC of
patients from endemic areas produce lower levels of IL-5 and IL-4
when exposed to D. pteronyssinus antigen (Der p1) than indivi-
duals with no helminth infection, resulting in lower levels of anti-
Der p1 IgE [14]. On the other hand, worm antigens exposure sti-
mulated by anthelmintic therapy promotes an increase of IL-5 and
IL-4 productions [15,16]. At the same time, IL-10 production is
suppressed, what may lead to IgE production including IgE anti-
Der p1 [17,18]. In vitro studies demonstrate that Praziquantel can
alter worm tegument, liberating or exposing inner worm antigens
can also stimulate IL-6, TNF-α and eotaxin production culminating
in antibodies isotypes changes over weeks or months [12,19–22].
Our data also support these ﬁndings as we showed that anti-
Derp1 IgE levels increase after treatment. We propose that thismight be related to decreased IL-10 resulting in increased IL-4
production.
Concerning geohelminths, it has been demonstrated that
Albendazole treatment was strongly associated with recurrent
wheeze [21]. Moreover, it was observed that Albendole treatment
during pregnancy enhances infantile eczema [23] and also
increases in anti-Der p1 IgE [24,25] In this study we demonstrated
that post-treatment response of individuals with high intensity of
infection of geohelminhths also have high levels of anti-Der p1 IgE
but the opposite was observed in the population with individuals
with low intensity of infection.
Rujeni and colleagues [26], found a negative correlation
between IgE anti-Der p1 and the intensity of S. mansoni infection
in high transmissions areas. The authors also did not observed
relationship between these two variables in low transmission
areas. In our study, the anti-Der p1 IgE levels ratio analysis after
and before treatment demonstrated that co-infected individuals
had higher levels of anti-Der p1 IgE after treatment than the other
groups of infected individuals evaluated. Although the increased
anti-Der p1 IgE index of co-infected/cured individuals was
observed, we did not observe a relationship between the intensity
of infection and anti-Der p1 IgE. This event might be explained by
the presence of different worms antigens released after treatment
of co-infected individuals exacerbated the IgE productions, prob-
ably by stimulating IL-4 production [27].
Fig. 4. Impact of treatment on Anti- Derp 1 IgE in two endemic areas for helminthic infection in Minas Gerais, Brazil. The frequency of “High anti-Der p1 IgE producers” and
the the status before and after treatment (NEG/ white; HW/ light grey; SCH/ dark grey and HW þ SCH/ black) were considered for population 1 (A) and population 2 (B).
Statistical analyses were performed by Fisher’s exact and by Mann–Whitney tests. Each group of the populations was compared before and after treatment with their
respective groups. In both cases signiﬁcance were considered at po0.05 and highlighted by *.
Fig. 5. Anti- Derp 1 IgE index. The index of anti- Der p1 IgE was deﬁned as ration of anti-Der p1 IgE optical density value before treatment and anti- Der p1 IgE optical
density value after treatment. The subgroups evaluated were those that presented negative results on Kato-Katz examinations. The groups were compared between them
(A). The anti- Der p1 IgE index of co-infected subgroup (before HWþSCH and after NEG) was correlated with intensity of infection (B). Statistical analyses were performed by
Fisher’s exact and by Mann–Whitney tests. In both cases signiﬁcance were considered at po0.05 and highlighted by *.
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taken with caution, considering some particularities of experi-
mental design and data collection approaches used in our study. In
fact, the population 1 measurements were performed 2 years after
treatment whereas the population 2 was assessed 3 years after
treatment. Moreover, the post-treatment samples were taken
years rather than weeks after treatment and therefore the infec-
tion level does not reﬂect efﬁcacy of treatment but rather rates of
re-infection in two areas with different rates of transmission. In
addition, the questionnaires were administered 7 and 2 years after
the beginning of the study in population 1 and 2, respectively.6. Conclusions
The determination whether helminth infections confer pro-
tection or are risk factor to allergic disorders and the effect of
anthelmintic treatment on allergic responses is still debatable.
Although we could not ﬁnd an association between helminth
intensity of infection and allergy related risk factors it was
demonstrated that effective chemotherapy of subjects from
endemic areas with high prevalence of infection enhances the
levels of anti-Der p1 IgE, that is a risk factor to allergic disorders
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